Home  |  About us  |  Editorial board  |  Ahead of print  | Current issue  |  Archives  |  Submit article  |  Instructions |  Search  |   Subscribe  |  Advertise  |  Contacts  |  Login 
  Users Online: 660Home Print this page Email this page Small font sizeDefault font sizeIncrease font size  

    Article Cited by others

REVIEW ARTICLE

Early access programs: Benefits, challenges, and key considerations for successful implementation

Patil Sanjaykumar

Year : 2016| Volume: 7| Issue : 1 | Page no: 4-8

   This article has been cited by
 
1 A retrospective study of trifluridine/tipiracil in pretreated metastatic colorectal cancer patients in clinical practice
Beatrice Borelli,Gemma Zucchelli,Daniele Rossini,Chiara Cremolini,Carlotta Antoniotti,Roberto Moretto,Federica Marmorino,Camilla Colombo,Francesca Vannini,Laura Delliponti,Mario Spione,Elena Ongaro,Gianluca Masi,Isa Maura Brunetti,Elisabetta Pfanner,Lisa Salvatore,Alfredo Falcone
Colorectal Cancer. 2018;
[Pubmed]  [Google Scholar] [DOI]
2 Identification, Prioritization, and Treatment of Mutations Identified by Next-Generation Sequencing
Aaron S. Mansfield,Ben Ho Park,Michael P. Mullane
American Society of Clinical Oncology Educational Book. 2018; (38): 873
[Pubmed]  [Google Scholar] [DOI]
3 Expanding Patient Access to Investigational New Drugs
Gail A. Van Norman
JACC: Basic to Translational Science. 2018; 3(3): 403
[Pubmed]  [Google Scholar] [DOI]
4 An overview of Compassionate Use Programs in the European Union member states
Gayathri Balasubramanian,Suman Morampudi,Pankdeep Chhabra,Arun Gowda,Behsad Zomorodi
Intractable & Rare Diseases Research. 2016; 5(4): 244
[Pubmed]  [Google Scholar] [DOI]

 

Read this article